**Semler Scientific Stock Surges Following Strong Q2 Results Fueled by Bitcoin Gains**
Semler Scientific (Nasdaq: SMLR) experienced a notable increase in its stock price, rising over 2.64% to $35.37 after the company announced its financial results for the second quarter of 2025. The surge in net income was primarily attributed to significant unrealized gains from its Bitcoin investments.
In its Q2 report, Semler Scientific revealed a net income of $66.9 million, a substantial rise from just $11,000 during the same period last year. This impressive growth occurred despite a 43% decline in revenue, which fell to $8.2 million. Operating expenses also increased to $10.3 million, leading to an operating loss of $2.1 million for the quarter. However, the company’s Bitcoin holdings generated an unrealized gain of $83.8 million, pushing pre-tax income to $80.6 million.
Eric Semler, the executive chairman of Semler Scientific, commented on the company’s progress with its Bitcoin treasury strategy, stating, “Year-to-date through July 31, 2025, this strategy has generated more than $110.4 million in unrealized gains and delivered a 31.3% BTC yield.” He also highlighted the company’s efforts to strengthen its ties to the Bitcoin community by appointing Natalie Brunell to the board of directors and hiring Joe Burnett as the director of Bitcoin strategy.
As of July 31, 2025, Semler reported holding 5,021 Bitcoins, valued at $586.2 million, an increase from 4,636 Bitcoins at the end of Q2. The company acquired approximately 1,829 Bitcoins during the quarter and July, investing a total of $195.4 million, funded through operating cash flow, investment monetization, and proceeds from equity and debt offerings.
Doug Murphy-Chutorian, CEO of Semler Scientific, expressed enthusiasm about the launch of CardioVanta, a wholly owned subsidiary aimed at advancing healthcare initiatives focused on early detection of heart failure and cardiac arrhythmia. He stated, “We believe CardioVanta positions us to deliver long-term value in our healthcare business as we continue to aggressively execute on our Bitcoin treasury strategy — establishing Semler Scientific as a dual-engine platform for growth.”
In addition to the new subsidiary, Semler Scientific entered into an at-the-market (ATM) equity offering agreement in April, allowing the company to issue and sell up to $500 million of its common stock. As of July 31, it had raised approximately $194.3 million under this agreement.
For those interested in further details, the full earnings call for Semler Scientific’s Q2 2025 results is available for viewing.
**FAQ**
**What drove Semler Scientific’s net income increase in Q2 2025?**
Semler Scientific’s net income increase in Q2 2025 was primarily driven by unrealized gains from its Bitcoin holdings, which amounted to $83.8 million, despite a decline in revenue.
